Stock NTHI NEONC TECHNOLOGIES HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Highlights Neonc Technologies Holdings, Inc.

Equities

NTHI

US64051A1016

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
NeOnc Technologies Receives FDA Approval to Expand NEO100-01 Phase 2a Clinical Trial to Include Patients with Recurrent Grade III Astrocytoma Brain Tumors Exhibiting IDH1 Mutation
CI
Neonc Technologies Holdings, Inc. has withdrawn its IPO in the amount of $82.5 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NTHI Stock
  4. News Neonc Technologies Holdings, Inc.
  5. Highlights